// App-Quantinova.ai

PO2209 : Narsoplimab, Another Tool in the Management of Thrombotic Microangiopathy in Stem Cell Transplant Recipients

Researchers

Presenter

  • Mamlouk Omar

Principal Investigators

  • Ahmed AliA

  • Coke HowardH

  • Mandayam SreedharA

Medical Centers

  • Section of Nephrology MD Anderson Cancer Center Houston Texas United States

  • Division of Renal Diseases and Hypertension University of Texas Health Science Center at Houston- McGovern Medical School Houston Texas United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Thrombotic microangiopathy

  • Acute lymphoblastic leukemia

  • Acute renal failure

  • Albuminuria

  • Sepsis

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Tacrolimus

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved